You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
In February 2021, Medtronic issued a global voluntary recall of the Medtronic Valiant Navion™ Thoracic Stent Graft System.
Recall Information for Healthcare Professionals
Recall Information for Patients
At Medtronic, we take any quality concerns with utmost seriousness, and the safety of patients is our primary concern. We will continue to develop high-quality therapies that positively impact lives. As technologies evolve, we continue to strive for the highest quality through enhanced systems, processes and products.
We have published a Performance Note about a rare mode in a population of some pacemakers and cardiac resynchronization therapy pacemakers. While in India we have received no (0) complaints, worldwide Medtronic has received three (3) complaints out of ~266,700 devices distributed worldwide since February 2017. The projected rate of occurrence for this issue is 0.0028 percent, with the most susceptible period being the first 12 months after a device is implanted.
These devices continue to perform well within reliability projections. In consultation with our Independent Physician Quality Panel, we do not recommend device replacement and recommend physicians (subject to the medical condition of the patient) to continue normal patient follow-up in accordance with standard practice and, where possible, to continue with remote monitoring.
In India, the Astra pacemaker, Solara CRT-P, and Serena CRT-P devices are available. We have been and continue to communicate proactively with the doctors and relevant stakeholders in India and have informed them about the performance note. There have been no patient issues reported in India related to this performance note.
Please note that this is not a case of a product recall.
If you have been implanted with these brand of pacemakers and want to know more please contact Response Care on 1800-419-6700